URETHRAL CANCER METASTATIC

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting URETHRAL CANCER METASTATIC:

# Drug Count
0 CARBOPLATIN 3
1 ASPIRIN 2
2 ASPIRIN 325 MG 2
3 ASPIRIN 81 MG 2
4 PACLITAXEL 2
5 ABIRATERONE ACETATE 1
6 ALENDRONATE SODIUM 1
7 ALPRAZOLAM 1
8 CALCIUM 1
9 CISPLATIN 1
See all common drugs associated with URETHRAL CANCER METASTATIC

URETHRAL CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERDAFITINIB 1 0.0008
1 MEGESTROL ACETATE 1 0.0003
2 NIACIN 1 0.0001
3 IFOSFAMIDE FOR INJECTION 1 0.0000
4 SODIUM BICARBONATE INJECTION, 1 0.0000
5 PROCHLORPERAZINE 1 0.0000
6 VALPROIC ACID 1 0.0000
7 SUNITINIB MALATE 1 0.0000
8 ABIRATERONE ACETATE 1 0.0000
9 CARBOPLATIN 3 0.0000
See all drugs enriched for association with URETHRAL CANCER METASTATIC

URETHRAL CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phenothiazine [EPC] 1 0.0000
1 Nicotinic Acid [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 2 0.0000
3 Integrin Receptor Antagonist [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 3 0.0000
5 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
6 5-alpha Reductase Inhibitor [EPC] 1 0.0000
7 Parathyroid Hormone Analog [EPC] 1 0.0000
8 Calcium [EPC] 1 0.0000
9 Mood Stabilizer [EPC] 1 0.0000
See all drug classes enriched for association with URETHRAL CANCER METASTATIC